The NF-κB pathway confers a survival advantage to cancer cells by modulating specific genes that control the balance between cell death and proliferation, thereby modulating processes of adaptive cellular plasticity of cancer cells to targeted therapies [130]. The gene discussed is NFKB1; the disease is cancer.